Results 171 to 180 of about 118,577,238 (222)

Nanoemulsion adjuvanted COBRA HA vaccine enhances protective antibody titers against H1N1 and H3N2 influenza viruses. [PDF]

Hum Vaccin Immunother
Thomas MH, Ross TM.
europepmc   +1 more source

Genetic and biological characterization of a reassortant H3N2 swine influenza virus isolated in China with internal genes from the 2009 pandemic H1N1. [PDF]

BMC Microbiol
Zhou X, Sun L, Yang J, Xia C, Zhao Y.
europepmc   +1 more source

Estimating the Relative Vaccine Efficacy of mRNA-1010 to High-Dose Influenza Vaccine in Adults ≥65 Years Using a Correlate of Protection Framework. [PDF]

Vaccines (Basel)
Nguyen VH, Settembre E, Youhanna J, Beck E, Van de Velde N, Joshi K.   +5 more
europepmc   +1 more source

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection. [PDF]

Virus Evol
Kikawa C, Huddleston J, Turner SA, Loes AN, Liu J, Gang S, Griffiths T, Drapeau EM, Cowling BJ, Ho F, Leung NHL, Englund JA, Lacombe K, Watanabe S, Hasegawa H, Busch M, Lanteri M, Stone M, Spencer B, Neher RA, Smith DJ, Bedford T, Hensley SE, Bloom JD.   +23 more
europepmc   +1 more source

Capillary-Driven Microfluidic Electrical Screening of Influenza H3N2-Infected A549 Cells Using AgNP-Decorated Laser-Patterned Villous Microstructures. [PDF]

Biosensors (Basel)
Chen Z, Tran MQ.
europepmc   +1 more source

Memory B Cell Repertoire of a Repeatedly Vaccinated Individual Includes Influenza Hemagglutinin-Specific Cross-Group Binders with Affinity Beyond A(H1N1)pdm09 and A(H3N2) Seasonal Strains. [PDF]

Vaccines (Basel)
Mishina M, Horn CM, Ende Z, Mishin V, Holiday C, Seenu S, Wilson JR, Cao W, Sheth M, Batra D, Chang J, Carney P, Levine MZ, Stevens J, Weigand MR, York IA, Gangappa S.   +16 more
europepmc   +1 more source

Molecular Characterization of Influenza A(H3N2) Hemagglutinin Variants Circulating in Western Mexico, 2022. [PDF]

Int J Mol Sci
Hernandez-Gonzalez KM, Carranza-Aranda AS, Muñoz-Valle JF, Muñoz-Miranda LA, Vega-Magaña AN, Pereira-Suárez AL, Nava-Valdivia CA.   +6 more
europepmc   +1 more source

A Cluster of Influenza A(H3N2) Viruses in 2024 From Tasmania, Australia, With Reduced Susceptibility to Baloxavir. [PDF]

Influenza Other Respir Viruses
Hussain S, Chia C, Muraleetharan A, Deng YM, Dong X, Chanthalavanh P, Takashita E, Dapat C, Miller JE, Peck H, Lee RTC, Williamson J, Cooley L, Maurer-Stroh S, Barr IG.   +14 more
europepmc   +1 more source